en

PRODUCT DETAIL

Hyrimoz 40 mg injekčný roztok v naplnenom pere

Code 8601C
MA number EU/1/18/1286/006
Product Form: sol inj 6 (3x2)x0,8 ml/40 mg (pero napl. SensoReady - multibal.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB04 Adalimumab
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 26.07.2018
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 26.01.2024
eu-flag.png sk-flag.png